Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Grant/Award of 91,633 WHWK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/Award | 91,633 | n/a |
| May 18, 2026 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/Award | 51,020 | $200.0K |
| Apr 15, 2026 | Whitehawk Therapeutics, Inc. (WHWK) | Sale | 26,389 | $91.3K |
| Apr 14, 2026 | Whitehawk Therapeutics, Inc. (WHWK) | Sale | 50,000 | $178.5K |
| Apr 3, 2026 | Whitehawk Therapeutics, Inc. (WHWK) | Exercise/Conversion | 366,532 | n/a |
| Mar 10, 2026 | Whitehawk Therapeutics, Inc. (WHWK) | Exercise/Conversion | 5,000 | n/a |
| Apr 3, 2025 | Whitehawk Therapeutics, Inc. (WHWK) | Grant/Award | 366,532 | n/a |
| Mar 4, 2025 | Aadi Bioscience, Inc. (AADI) | Exercise/Conversion | 5,000 | n/a |